October 5th- Rethinking Induction in Fit AML: Can Azacitidine–Venetoclax Challenge Intensive Chemotherapy?

CME Congresses .

October 5th- Rethinking Induction in Fit AML: Can Azacitidine–Venetoclax Challenge Intensive Chemotherapy?

October 5th- Prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q

CME Congresses .

October 5th- Prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q

September 30th- Beyond the Webinar: Unusual-Site Thrombosis in Myeloproliferative Neoplasms: When Thrombosis Comes Before the Diagnosis

CME Congresses .

September 30th- Beyond the Webinar: Unusual-Site Thrombosis in Myeloproliferative Neoplasms: When Thrombosis Comes Before the Diagnosis

September 28th- From Clonal Expansion to Clonal Eradication: Is a New Era Beginning in Myeloproliferative Neoplasms?

CME Congresses .

September 28th- From Clonal Expansion to Clonal Eradication: Is a New Era Beginning in Myeloproliferative Neoplasms?

September 26th- Live from IMS 2026: Take-Home Message and Summary of IMS 2026

CME Congresses .

September 26th- Live from IMS 2026: Take-Home Message and Summary of IMS 2026

September 26th- Live from IMS 2026: The IMS 2026 Debate

CME Congresses .

September 26th- Live from IMS 2026: The IMS 2026 Debate

September 25th- Live from IMS 2026: Plenary session of the 23rd Annual Meeting of the International Myeloma Society

CME Congresses .

September 25th- Live from IMS 2026: Plenary session of the 23rd Annual Meeting of the International Myeloma Society

September 24th- Live from IMS 2026: Can the gut microbiome influence the efficacy and toxicity of CAR-T cells — and could we eventually manipulate it to improve patient outcomes?

CME Congresses .

September 24th- Live from IMS 2026: Can the gut microbiome influence the efficacy and toxicity of CAR-T cells — and could we eventually manipulate it to improve patient outcomes?

September 23rd- Live from IMS 2026: T-cell Engagers to Reorganize the Cytotoxic Immunological Synapse

CME Congresses .

September 23rd- Live from IMS 2026: T-cell Engagers to Reorganize the Cytotoxic Immunological Synapse

September 23rd- Live from IMS 2026: Rethinking First Relapse in Multiple Myeloma: CAR-T, Bispecifics, ADCs and the Challenge of Sequencing

CME Congresses .

September 23rd- Live from IMS 2026: Rethinking First Relapse in Multiple Myeloma: CAR-T, Bispecifics, ADCs and the Challenge of Sequencing